| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |